https://www.selleckchem.com/pr....oducts/omaveloxolone
Posterior glenoid bone loss is commonly associated with primary glenohumeral osteoarthritis. Surgical management of bone loss in anatomic total shoulder arthroplasty (aTSA) remains controversial. We studied the use of a stepped augmented glenoid component for management of Walch B2 and B3 glenoids and compared the radiographic and clinical outcomes at short-term follow-up with those achieved with a non-augmented component of the same design in Walch A1 glenoids. Ninety-two patients (42 A1, 29 B2, and 21 B3 glenoids) were p
Like
Comment
Share
